http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 20 Feb 2026 16:27:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Feb+19/26036452.html si-local-file:///var/storage/secattach/20260220/26036452.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Feb+19/26036452.html Fri, 20 Feb 2026 16:27:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Feb+19/26036452.html si-local-file:///var/storage/secattach/20260220/26036452.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Feb+19/26036452.html Fri, 20 Feb 2026 16:27:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+BML+Investment+Partners%2C+L.P./25967378.html si-local-file:///var/storage/secattach/20260209/25967378.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+BML+Investment+Partners%2C+L.P./25967378.html Mon, 09 Feb 2026 14:14:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+BML+Investment+Partners%2C+L.P./25967378.html si-local-file:///var/storage/secattach/20260209/25967378.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ORAMED+PHARMACEUTICALS+++++++++++++++++Filed+by%3A+BML+Investment+Partners%2C+L.P./25967378.html Mon, 09 Feb 2026 14:14:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Kidron+Miriam/25916404.html si-local-file:///var/storage/secattach/20260129/25916404.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Kidron+Miriam/25916404.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Kidron+Miriam/25916404.html si-local-file:///var/storage/secattach/20260129/25916404.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Kidron+Miriam/25916404.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Hexter+Joshua/25916406.html si-local-file:///var/storage/secattach/20260129/25916406.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Hexter+Joshua/25916406.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Hexter+Joshua/25916406.html si-local-file:///var/storage/secattach/20260129/25916406.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Hexter+Joshua/25916406.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+KIDRON+NADAV/25916408.html si-local-file:///var/storage/secattach/20260129/25916408.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+KIDRON+NADAV/25916408.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+KIDRON+NADAV/25916408.html si-local-file:///var/storage/secattach/20260129/25916408.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+KIDRON+NADAV/25916408.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Gabay+Avraham/25916409.html si-local-file:///var/storage/secattach/20260129/25916409.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Gabay+Avraham/25916409.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Gabay+Avraham/25916409.html si-local-file:///var/storage/secattach/20260129/25916409.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+22++Filed+by%3A+Gabay+Avraham/25916409.html Thu, 29 Jan 2026 16:06:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+14++Filed+by%3A+Kidron+Miriam/25875770.html si-local-file:///var/storage/secattach/20260121/25875770.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+14++Filed+by%3A+Kidron+Miriam/25875770.html Wed, 21 Jan 2026 16:30:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+14++Filed+by%3A+Kidron+Miriam/25875770.html si-local-file:///var/storage/secattach/20260121/25875770.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+14++Filed+by%3A+Kidron+Miriam/25875770.html Wed, 21 Jan 2026 16:30:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+12/25850362.html si-local-file:///var/storage/secattach/20260114/25850362.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+12/25850362.html Wed, 14 Jan 2026 16:31:00 -0500 O.56010000 ORMP http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+12/25850362.html si-local-file:///var/storage/secattach/20260114/25850362.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ORAMED+PHARMACEUTICALS++++For%3A+Jan+12/25850362.html Wed, 14 Jan 2026 16:31:00 -0500 O.56010000 ORMP http://www.streetinsider.com/Corporate+News/Lifeward+enters+%2447+million+strategic+partnership+with+Oramed/25840982.html <p>Lifeward Ltd. (NASDAQ: LFWD) announced a strategic partnership with Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) that includes up to $47 million in funding and the acquisition of Oramed's protein oral delivery technology platform.</p> <p>Under the agreement, which requires shareholder approval, Oramed will acquire up to 49.99% equity ownership in Lifeward through ordinary shares, prefunded warrants, and additional warrants worth up to $7 million. The funding structure includes $10 million in convertible notes from Oramed and another investor, with an additional $10 million triggered upon achieving revenue or share price milestones.</p> <p>Lifeward will acquire Oramed's POD technology, designed to convert injectable biological therapies into http://www.streetinsider.com/Corporate+News/Lifeward+enters+%2447+million+strategic+partnership+with+Oramed/25840982.html Tue, 13 Jan 2026 08:00:48 -0500 LFWD ORMP http://www.streetinsider.com/Corporate+News/Lifeward+enters+%2447+million+strategic+partnership+with+Oramed/25840982.html <p>Lifeward Ltd. (NASDAQ: LFWD) announced a strategic partnership with Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) that includes up to $47 million in funding and the acquisition of Oramed's protein oral delivery technology platform.</p> <p>Under the agreement, which requires shareholder approval, Oramed will acquire up to 49.99% equity ownership in Lifeward through ordinary shares, prefunded warrants, and additional warrants worth up to $7 million. The funding structure includes $10 million in convertible notes from Oramed and another investor, with an additional $10 million triggered upon achieving revenue or share price milestones.</p> <p>Lifeward will acquire Oramed's POD technology, designed to convert injectable biological therapies into http://www.streetinsider.com/Corporate+News/Lifeward+enters+%2447+million+strategic+partnership+with+Oramed/25840982.html Tue, 13 Jan 2026 08:00:48 -0500 LFWD ORMP http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Press+Releases/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html <p align="center"><em>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential</em></p> <p align="center"><em>Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech</em></p> <p align="center"><em>Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity </em></p> <p align="center"><em>POD™ targets the $600+ billion injectable drugs market, including ORMD-0801, which has the potential to become the world’s first commercialized oral insulin medicine </em></p> <p align="justify">MARLBOROUGH, Mass.&#160;and http://www.streetinsider.com/Globe+Newswire/Lifeward+Enters+Transformative+Strategic+Investment+and+Partnership+Agreement+with+Oramed+to+Create+a+Diversified+Biomedical+Innovation+Company/25840850.html Tue, 13 Jan 2026 08:00:00 -0500 LFWD ORMP ORMP http://www.streetinsider.com/Trading+Halts/Oramed+to+transfer+drug+delivery+tech+to+Lifeward+for+49.9%25+stake/25840817.html <p>Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) and Lifeward Ltd. (NASDAQ: LFWD) announced a strategic transaction that will transfer Oramed's oral drug delivery platform to Lifeward in exchange for a 49.9% beneficial ownership interest in the medical robotics company.</p><p>Under the agreement, Oramed will transfer its Protein Oral Drug (POD™) technology to Lifeward while retaining management of the clinical program. Lifeward will issue $10 million in senior secured convertible notes through a private placement, with Oramed investing $9 million. An additional milestone-based $10 million convertible note may be issued, with Oramed contributing another $9 million.</p><p>The convertible notes carry 8% annual interest and include http://www.streetinsider.com/Trading+Halts/Oramed+to+transfer+drug+delivery+tech+to+Lifeward+for+49.9%25+stake/25840817.html Tue, 13 Jan 2026 07:58:44 -0500 LFWD OJU1 ORMP